Search Results for: HCV

November 17, 2016November 17, 2016

AbbVie’s HCV Therapy Looks Highly Effective in Patients with Severe Kidney Disease

Hepatitis C, News

AbbVie recently announced positive results for the company’s investigational regimen of glecaprevir/pibrentasvir (G/P) in treating patients with chronic hepatitis C virus (HCV). Results are from the EXPEDITION-4 study (NCT02651194), an open-label Phase ... Read more

September 22, 2016September 22, 2016

Penn Medicine Launches Clinical Trial to Transplant Kidneys from HCV-positive Donors

Hepatitis C, News

A research team at Penn Medicine launched a clinical trial examining the effectiveness and safety of using kidneys from deceased donors who had hepatitis C virus (HCV) for patients without the infection, ... Read more

July 7, 2016July 7, 2016

HCV Treatment Path 4.0 App Includes Latest Medication Guidelines

Hepatitis C, News

Altamonte Springs, Florida based BioPlus Specialty Pharmacy released an update and expansion of its hepatitis C virus (HCV) Treatment Path prescriber app to help guide selection of a hepatitis C therapy. ... Read more

February 9, 2016February 9, 2016

Exposure to Hepatitis C Is Recurrent Among West African Inhabitants, Who Have Multiple Contacts With HCV

News

West African inhabitants have recurrent occasions for exposure to the hepatitis C virus (HCV), according to the findings of a recent review conducted by a team of Loyola University Medical Center ... Read more

September 22, 2015September 24, 2015

Rate of HCV incidence Is Increasing In HIV+ Men Who Have Sex With Men, According to Study

News

Incidence epidemiology of sexually transmitted hepatitis C virus (HCV) infection in HIV-positive men who have sex with men (MSM) is only partially understood. However, it is known that in the ... Read more

August 4, 2015August 4, 2015

FDA Approves Once-Daily TECHNIVIE for HCV Genotype 4

News

On July 2015, the US Food and Drug Administration granted final approval of AbbVie’s TECHNIVIE (ombitasvir, paritaprevir and ritonavir), a fixed-dose combination drug classified as a hepatitis C virus NS5A ... Read more

July 30, 2015July 31, 2015

Patients Co-Infected With HCV and HIV Receive More Effective Treatments

News

Results from a recently released study show that HIV and Hepatitis-C virus (HCV) co-infected patients who had not previously been treated for hepatitis C, but received 12 weeks of treatment ... Read more

May 5, 2015May 5, 2015

New Drug Shows Promise In Treating Chronic HCV Patients With Liver Transplant And Advanced Liver Disease

Hepatitis C, News

Hepatitis C is one of the worst forms of liver diseases affecting people in the world today — around 3.2 million have HCV in the United States alone. Spread mostly from ... Read more

April 28, 2015April 28, 2015

Gilead’s Drugs Harvoni and Sovaldi Prove to Be Safe and Effective in Patients with Advanced Liver Disease Associated with HCV

Hepatitis C, News

Gilead Sciences, Inc. recently announced in a press release the promising results from several Phase 2 clinical trials assessing the use of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) and Sovaldi® (sofosbuvir ... Read more

April 24, 2015April 24, 2015

Rapid HCV Test Approved In Europe

Hepatitis C, News

Cepheid recently announced that its quantitative hepatitis C virus infection viral load test, Xpert HCV Viral Load, has achieved CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices. ... Read more